Jury Awards Infosint $15M In Lexapro Patent Fight

Law360, New York (October 19, 2009, 5:32 PM EDT) -- Lundbeck A/S and Forest Laboratories Inc. will have to pay Infosint SA a $15 million reasonable royalty award now that a federal jury has ruled that Infosint's patent for making the antidepressant citalopram is valid.

A jury in the U.S. District Court for the Southern District of New York on Thursday found that a process used by Lundbeck for making racemic citalopram and escitalopram, the active ingredients in the antidepressant, infringed Infosint's patented process for making 5-carboxyphthalide, a starting material for the synthesis of citalopram....
To view the full article, register now.